StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Arcus Biosciences — Total assets by Quarter

Arcus Biosciences — Total assets ($M) ($M)

QuarterlyAnnual

Gilead Sciences Arcus Biosciences — Total assets: $924M in Q2 2026, down 14.0% from a year earlier.

Latest, Q2 2026
924
Period ended Jun 30, 2026
Change on a year earlier
-14.0%
1,075 in Q2 2025
History
30 quarters
Since Q1 2019
Sources
29
Documents cited below

Where the Q2 2026 figure comes from

Source: Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗

Reported in Arcus Biosciences (RCUS) Form 10-Q / 10-K Balance Sheets.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedArcus Biosciences — Total assets ($M) ($M)Year on yearSource
Q2 2026Jun 30, 2026924-14.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026997-13.8%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 20251,139-1.0%Arcus Biosciences (RCUS) Form 10-Q (filed 2026-08-05) ↗
Q3 2025Sep 30, 2025974-22.2%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-10-28) ↗
Q2 2025Jun 30, 20251,075-9.4%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-08-06) ↗
Q1 2025Mar 31, 20251,156-10.6%Arcus Biosciences (RCUS) Form 10-Q (filed 2025-05-06) ↗
Q4 2024Dec 31, 20241,150+5.0%Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗
Q3 2024Sep 30, 20241,252+5.1%Arcus Biosciences (RCUS) Form 10-Q (filed 2024-11-06) ↗
Q2 2024Jun 30, 20241,186-2.8%Arcus Biosciences (RCUS) Form 10-Q (filed 2024-08-08) ↗
Q1 2024Mar 31, 20241,293+3.1%Arcus Biosciences (RCUS) Form 10-Q (filed 2024-05-08) ↗
Q4 2023Dec 31, 20231,095-18.6%Arcus Biosciences (RCUS) Form 10-K (filed 2025-02-25) ↗
Q3 2023Sep 30, 20231,191-14.6%SEC Filing ↗
Q2 2023Jun 30, 20231,220-17.4%SEC Filing ↗
Q1 2023Mar 31, 20231,254-18.8%SEC Filing ↗
Q4 2022Dec 31, 20221,345-15.5%Arcus Biosciences (RCUS) Form 10-K (filed 2024-02-21) ↗
Q3 2022Sep 30, 20221,394+66.1%SEC Filing ↗

Breakdown

What makes up arcus Biosciences — Total assets

Cite this data

StockData. (2026). Gilead Sciences Arcus Biosciences — Total assets ($M), quarterly Q1 2019–Q2 2026 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rcus-assets-tot

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.